Hormone replacement therapy and ischemic stroke severity in women: A case-control study

Neurology

Volumn 56, Issue 10, 2001, Pages 1304-1307

  Bushnell, Cheryl D ^a   Samsa, Gregory P ^b   Goldstein, Larry B ^a,b,c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY   (United States)

^c DURHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN;

ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; ESTROGEN THERAPY; FEMALE; HORMONE SUBSTITUTION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NEUROPROTECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; STROKE;

EID: 0035933157     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.56.10.1304     Document Type: Article

References (39)

1. Women, heart disease, and stroke statistics. Heart and Stroke Statistical Update. Dallas, TX: American Heart Association, 2000.
2. Barrett-Connor E. Sex differences in coronary heart disease: why are women so superior? Circulation 1997;95:252-264.
3. Rosenberg SH, Fausone V, Clark R. The role of estrogens as a risk factor for stroke in postmenopausal women. West J Med 1980;133:292-296.
4. Falkeborn M, Persson I, Terent A, et al. Hormone replacement therapy and the risk of stroke. Arch Intern Med 1993;153: 1201-1209.
5. Grodstein F, Stampfer MJ, Manson JE, et al. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 1996;335:453-461.
6. Petitti DB, Sidney S, Quesenberry CP, Jr., et al. Ischemic stroke and use of estrogen and estrogen/progestogen as hormone replacement therapy. Stroke 1998;29:23-28.
7. Fung MM, Barrett-Connor E, Bettencourt RR. Hormone replacement therapy and stroke risk in older women. J Womens Health 1999;8:359-364.
8. Pederson AT, Lidegaard O, Kreiner S, et al. Hormone replacement therapy and risk of non-fatal stroke. Lancet 1997;350: 1277-1283.
9. Finucane F, Madans JH, Bush TL, et al. Decreased risk of stroke among postmenopausal hormone users: results from a national cohort. Arch Intern Med 1993;153:73-79.
10. Lindenstrom E, Boysen G, Nyboe J. Lifestyle factors and risk of cerebrovascular disease in women: the Copenhagen City Heart Study. Stroke 1993;24:1468-1472.
11. Wilson PW, Garrison RJ, Castelli WP. Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. N Engl J Med 1985;313:1038-1043.
12. Grady D, Rubin SM, Petitti DB, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992;117:1016-1037.
13. Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 1998;280:605-613.
14. Alkayed NJ, Harukuni I, Kimes AS, et al. Gender-linked brain injury in experimental stroke. Stroke 1998;29:159-165.
15. Rusa R, Alkayed NJ, Crain BJ, et al. 17 beta-estradiol reduces stroke injury in estrogen-deficient female animals. Stroke 1999;30:1665-1670.
16. Fukuda K, Yao H, Ibayashi S, et al. Ovariectomy exacerbates and estrogen replacement attenuates photothrombotic focal ischemic brain injury in rats. Stroke 2000;31:155-160.
17. Wang Q, Santizo R, Baughman VL, et al. Estrogen provides neuroprotection in transient forebrain ischemia through perfusion-independent mechanisms in rats. Stroke 1999;30: 630-637.
18. Alkayed NJ, Murphy SJ, Traystman RJ, et al. Neuroprotective effects of female gonadal steroids in reproductively senescent female rats. Stroke 2000;31:161-168.
19. Yang SH, Shi J, Day AL, et al. Estradiol exerts neuroprotective effects when administered after ischemic insult. Stroke 2000;31:745-749; discussion 749-750.
20. Paganini-Hill A, Ross RK, Henderson BE. Postmenopausal oestrogen treatment and stroke: a prospective study. BMJ 1988;297:519-522.
21. Sourander L, Rajala T, Raiha I, et al. Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on oestrogen replacement therapy (ERT). Lancet 1998;352:1965-1969.
22. Henderson BE, Paganini-Hill A, Ross RK. Decreased mortality in users of estrogen replacement therapy. Arch Intern Med 1991;151:75-78.
23. Schairer C, Adami H-O, Hoover R, et al. Cause-specific mortality in women receiving hormone replacement therapy. Epidemiology 1997;8:59-65.
24. Adams HP, Bendixen BH, Rappelle LJ, et al. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. Stroke 1993;24:35-41.
25. Cote R, Battista R, Wolfson C, et al. The Canadian Neurological Scale: validation and reliability assessment. Neurology 1989;39:638-643.
26. Bushnell CD, Johnston DC, Goldstein LB. Retrospective assessment of initial stroke severity: comparison of the NIHSS and the CNS. Stroke 2001;32:656-660.
27. Goldstein LB, Chilukuri V. Retrospective assessment of initial stroke severity with the Canadian Neurological Scale. Stroke 1997;28:1181-1184.
28. Pelligrino DA, Santizo R, Baughman VL, et al. Cerebral vasodilating capacity during forebrain ischemia: effects of chronic estrogen depletion and repletion and the role of neuronal nitric oxide synthase. Neuroreport 1998;9:3285-3291.
29. Alkayed N, McCune S, Crain B, et al. Estrogen-enhanced expression of bcl-2 mRNA in rat brain after experimental stroke. FASEB J 1998;12:A954. Abstract.
30. Garcia-Segura L, Cardona-Gomez P, Naftolin F, et al. Estradiol upregulates bcl2 expression in adult brain neurons. Neuroreport 1998;9:593-597.
31. Singer C, Rogers K, Strickland T, et al. Estrogen protects primary cortical neurons from glutamate toxicity. Neurosci Lett 1996;212:13-16.
32. Culmsee C, Vedder H, Ravati A, et al. Neuroprotection by estrogens in a mouse model of focal cerebral ischemia and in cultured neurones: evidence for a receptor-independent antioxidative mechanism. J Cereb Blood Flow Metab 1999;19: 1263-1270.
33. Chalbos D, Philips A, Rochefort H. Genomic cross-talk between the estrogen receptor and growth factor regulatory pathways in estrogen target tissues. Cancer Biol 1994;5:361-368.
34. Santizo RA, Anderson S, Ye S, et al. Effects of estrogen on leukocyte adhesion after transient forebrain ischemia. Stroke 2000;31:2231-2235.
35. Lavy S, Stern S, Melamed E, et al. Effect of chronic atrial fibrillation on regional cerebral blood flow. Stroke 1980;11:35-38.
36. Censori B, Camerlingo M, Casto L, et al. Prognostic factors in first-ever stroke in the carotid artery territory seen within 6 hours after onset. Stroke 1993;24:532-535.
37. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 1995;273:199-208.
38. Frankel M, Morgenstern L, Kwiatkowski T, et al. Predicting prognosis after stroke. A placebo group analysis from the National Institute of Neurological Disorders and Stroke rt-PA Stroke Trial. Neurology 2000;55:952-959.
39. Jongbloed L. Prediction of function after stroke: a critical review. Stroke 1986;17:765-776.